Cortese, A, Dohrn, MF, Curro, R, Negri, S, Lassuthova, P, Pisciotta, C, Tozza, S, Al-Ajmi, A, Feng, CY, Tomaselli, PJ, Fernandez-Eulate, G, Haddad, S, Laurà, M, Rossor, AM, Vegezzi, E, Facchini, S, Sleigh, JN, Rebelo, A, Beijer, D, Raposo, J, Saporta, M, Lauerova, B, Pernice, HF, Achenbach, P, Schöne, U, Alon, T, Deschauer, M, Cordts, I, Obermaier, CD, Winter, N, Creigh, PD, Sowden, JE, Rehbein, T, Magri, S, Bertini, A, Saveri, P, Ripellino, P, Huang, JY, Nadaj-Pakleza, A, Ross, A, Holt, JKL, Brennan, KM, Sukenik-Halevy, R, Bizaoui, V, Parman, Y, Battaloglu, E, Cakar, A, Alrohaif, H, Hammans, S, Kumar, KR, Kennerson, ML, Kayserili, H, Amado, DA, Hahn, K, Valentino, P, Cavalcanti, F, Gaetano, C, Taroni, F, Braathen, GJ, Houlden, H, Stojkovic, T, Peric, S, Bolino, A, Previtali, SC, Lee, YC, Basak, AN, Hamed, SA, Rojas-Garcia, R, Claeys, KG, Marques, W, Sevilla, T, Schlotter-Weigel, B, Manganelli, F, Zhang, RX, Herrmann, DN, Scherer, SS, Seeman, P, Pareyson, D, Reilly, MM, Shy, ME, Züchner, S. Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD. BRAIN. 2025; 148(10)DOI:10.1093/brain/awaf021. PMID:39938083. IF:11.700(Q1/1D).

Llansó, L, Stevanovski, I, Morís, G, Collet-Vidiella, R, Segarra-Casas, A, González-Quereda, L, Rodríguez-Santiago, B, Gallano, P, Alvarez, R, Vesperinas, A, Blanco, R, San-Millán, B, Navarro, C, Illa, I, Ravenscroft, G, Deveson, IW, Gallardo, E, Olivé, M. Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal Features. Annals of Clinical and Translational Neurology. 2025; 12(10)DOI:10.1002/acn3.70146. PMID:40693562. IF:3.900(Q1/3D).

Gómez-Andrés, D, Costa-Comellas, L, Díaz-Manera, J, Ounap, K, Alvarez-Molinero, M, Urcuyo, G, Savarese, M, Munell, F, Udd, B. Different Lower Limb Muscle MRI Patterns in Autosomal Dominant Titinopathies. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32(10)DOI:10.1111/ene.70348. PMID:41025552. IF:3.900(Q1/3D).

Iammarino, MA, Alonso-Perez, J, Stojkovic, T, Pegoraro, E, Lowes, L, Diaz-Manera, J. 282nd ENMC international workshop-standards of diagnosis and care for the sarcoglycanopathies. 8-10 November 2024, Amsterdam, Netherlands. NEUROMUSCULAR DISORDERS. 2025; 54DOI:10.1016/j.nmd.2025.106212. PMID:40997622. IF:2.800(Q2/5D).

Querol, L, Rinaldi, S, Borsi, A, Boggia, GM, de Courcy, J, Taylor, Y, Wright, J, Karmous, W, Noel, W, Gary, C, zu Hörste, GM. Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:10.1111/jns.70047. PMID:40826893. IF:3.200(Q2/4D).

de Frutos, F, Herrador, L, Peiró-Aventin, B, Eiros, R, Freire, JL, Zorio, E, Carbayo, A, Llongueras-Espi, P, Garcia-Alvarez, A, Ripoll-Vera, T, Macias, R, Vilches, S, Ruiz-Bustillo, S, Arana-Achaga, X, Ordás, JG, Piqueras-Flores, J, Ruiz-Cueto, M, Casasnovas, C, Tirón, C, Rojas-Garcia, R, Sevilla, T, Rodriguez-Palomares, JF, González-López, E, Villacorta, E, Garcia-Pavia, P, González-Costello, J. Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(9)DOI:10.1016/j.rec.2024.12.012. PMID:39827963. IF:4.900(Q1/2D).

Kishnani, PS, Boentert, M, Wenninger, S, Berger, KI, Msihid, J, O'Callaghan, L, Essadi-Addou, R, Gallego, V, Rawat, NS, Huynh-Ba, O, Diaz-Manera, J. Efficacy of Switching Therapy From Alglucosidase Alfa to Avalglucosidase Alfa on Respiratory Function in Participants With Late-Onset Pompe Disease: A Post Hoc Analysis From the COMET Trial. Jimd Reports. 2025; 66(5)DOI:10.1002/jmd2.70033. PMID:40799512. IF:(Q/D).

Kushlaf, H, Díaz-Manera, J, Bratkovic, D, Byrne, BJ, Claeys, KG, Clemens, PR, Dimachkie, MM, Kishnani, PS, Laforêt, P, Roberts, M, Schoser, B, Toscano, A, Castelli, J, Holdbrook, F, Das, SS, Goldman, M, Mozaffar, T. Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL. MUSCLE & NERVE. 2025; 72(2)DOI:10.1002/mus.28420. PMID:40342075. IF:3.100(Q2/4D).

Schiava, M, Parkhurst, Y, Henderson, M, Polvikoski, T, Valtcheva, MV, Nishino, I, Inoue, M, Nishimori, Y, Saito, Y, Stojkovic, T, Villar-Quiles, RN, Romero, NB, Evangelista, T, Malfatti, E, Souvannanorath, S, Pegoraro, E, Riguzzi, P, Monforte, M, Bortolani, S, Torchia, E, Sabatelli, M, Tasca, G, Straub, V, Marini-Bettolo, C, Guglieri, M, Cetin, H, Gelpi, E, Klotz, S, De Bleecker, JL, Alonso-Jimenez, A, Baets, J, De Ridder, W, De Jonghe, P, Claeys, KG, Thal, DR, Bevilacqua, JA, Luo, SS, Zhu, WH, Lin, J, Papadimas, G, Papadopoulos, C, Zamba-Papanicolaou, E, Xirou, S, Pal, E, Rodolico, C, Kostera-Pruszczyk, A, Kierdaszuk, B, Kaminska, A, Muelas, N, Vilchez, JJ, Domínguez-González, C, Hernandez-Lain, A, Alonso-Perez, J, Nedkova-Hristova, V, Aledo, C, Oldfors, A, Badrising, UA, Kushlaf, H, Lloyd, TE, Ikenaga, C, Alfano, LN, Quinn, CC, Walk, D, Vorgerd, M, Weihl, C, Olivé, M, Diaz-Manera, J, VCP Int Study Grp. Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy. Neurology-Genetics. 2025; 11(4)DOI:10.1212/NXG.0000000000200265. PMID:40678441. IF:3.700(Q1/3D).

Segarra-Casas, A, Domínguez-González, C, Natera-de Benito, D, Kapetanovic, S, Hernández-Laín, A, Estévez-Arias, B, Llansó, L, Ortez, C, Jou, C, Martí-Carrera, I, López-Márquez, A, Rodríguez, MJ, González-Mera, L, Nedkova, V, Fernández-Torrón, R, Rodríguez-Santiago, B, Jimenez-Mallebrera, C, Juntas-Morales, R, López-de Munain, A, Surrallés, J, Nascimento, A, Gallardo, E, Olivé, M, Gallano, P, González-Quereda, L. Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases. Annals of Clinical and Translational Neurology. 2025; 12(7)DOI:10.1002/acn3.70078. PMID:40413734. IF:3.900(Q1/3D).

Dewilde, S, Tollenaar, NH, Boulanger, P, Archer, A, Pardo, R, Cortés-Vicente, E, Mantegazza, R, Vanoli, F, Lehnerer, S, Pawlitzki, M, Heinrich, M, De Ruyck, F, Phillips, G, Paci, S. Caregiving burden among caregivers of people with myasthenia gravis. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-025-03842-w. PMID:40537818. IF:3.500(Q2/4D).

Alonso-Pérez, J, Barrachina-Esteve, O, Gonzaález-Quereda, L, Viguera-Martinez, ML, Lujaán-Torné, M, Guitart-Feliubadaló, M, Martínez, JM, Carbayo, A, Gallano, P, Díaz-Manera, J, Olivé, M, Rojas-Garcia, R. Novel DES mutation presenting with isolated restrictive respiratory failure. Expanding the clinical spectrum. NEUROLOGIA. 2025; 40(5)DOI:10.1016/j.nrl.2023.03.002. PMID:40523712. IF:3.100(Q2/4D).

Verdu-Diaz, J, Bolano-Díaz, C, Gonzalez-Chamorro, A, Fitzsimmons, S, Warman-Chardon, J, Kocak, GS, Mucida-Alvim, D, Smith, IC, Vissing, J, Poulsen, NS, Luo, SS, Domínguez-González, C, Bermejo-Guerrero, L, Gomez-Andres, D, Sotoca, J, Pichiecchio, A, Nicolosi, S, Monforte, M, Brogna, C, Mercuri, E, Bevilacqua, JA, Díaz-Jara, J, Pizarro-Galleguillos, B, Krkoska, P, Alonso-Pérez, J, Olivé, M, Niks, EH, Kan, HE, Lilleker, J, Roberts, M, Buchignani, B, Shin, J, Esselin, F, Le Bars, E, Childs, AM, Malfatti, E, Sarkozy, A, Perry, L, Sudhakar, S, Zanoteli, E, Di Pace, FT, Matthews, E, Attarian, S, Bendahan, D, Garibaldi, M, Fionda, L, Alonso-Jiménez, A, Carlier, R, Okhovat, AA, Nafissi, S, Nalini, A, Vengalil, S, Hollingsworth, K, Marini-Bettolo, C, Straub, V, Tasca, G, Bacardit, J, Díaz-Manera, J. Myo-Guide: A Machine Learning-Based Web Application for Neuromuscular Disease Diagnosis With MRI. Journal of Cachexia Sarcopenia and Muscle. 2025; 16(3)DOI:10.1002/jcsm.13815. PMID:40275674. IF:9.100(Q1/1D).

Sacconi, S, Vanoli, F, Stascheit, F, Cortés-Vicente, E, Mantegazza, R, Meisel, A. 278th ENMC International Workshop: European standards for harmonization of myasthenia gravis registries and emerging digital solutions. 20th-21st September 2024, Hoofddorp, The Netherlands. NEUROMUSCULAR DISORDERS. 2025; 51DOI:10.1016/j.nmd.2025.105368. PMID:40388880. IF:2.800(Q2/5D).

Habib, AA, Claeys, KG, Bril, V, Hussain, Y, Gwathmey, K, Sahagian, G, Cortés-Vicente, E, Brauer, E, Gelinas, D, Sumbul, A, Jimenez, RH, Hristova, D, Masschaele, D, Mantegazza, R, Meisel, A, Attarian, S. ADAPT NXT: Fixed Cycles or Every-Other-Week IV Efgartigimod in Generalized Myasthenia Gravis. Annals of Clinical and Translational Neurology. 2025; 12(6)DOI:10.1002/acn3.70051. PMID:40223516. IF:3.900(Q1/3D).

Balla, A, Saraceno, F, Rullo, M, Morales-Conde, S, Soler, EMT, Di Saverio, S, Guerrieri, M, Lepiane, P, Di Lorenzo, N, Adamina, M, Alarcon, I, Arezzo, A, Rodriguez, JB, Boni, L, Biondo, S, Carrano, FM, Chand, M, Jenkins, JT, Davies, J, Rivilla, SD, Delrio, P, Elmore, U, Espin-Basany, E, Fichera, A, Lorente, BF, Francis, N, Ruiz, MG, Hahnloser, D, Licardie, E, Martinez, C, Ortenzi, M, Panis, Y, Idoate, CP, Paganini, AM, Pera, M, Perinotti, R, Popowich, DA, Rockall, T, Rosati, R, Sartori, A, Scoglio, D, Shalaby, M, Fernandez, VS, Smart, NJ, Spinelli, A, Sylla, P, Tanis, PJ, Hernandez, JV, Wexner, SD, Sileri, P, PICARR Collaborative Grp. Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey. Updates in Surgery. 2025; 77(3)DOI:10.1007/s13304-025-02111-6. PMID:40121358. IF:2.200(Q2/4D).

López-Gutiérrez, F, Loricera, J, Molina-Collada, J, Gonáalez, JCN, Sánchez-Lucas, M, Moya, P, Labrador-Sánchez, E, Ferraz-Amaro, I, Blanco, R. SWITCHING FROM REFERENCE TOCILIZUMAB TO BIOSIMILAR IN GIANT CELL ARTERITIS: EFFECTIVENESS AND SAFETY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3604. PMID:. IF:20.600(Q1/1D).

Espino-Guarch, M, Huang, SSY, Vilches, C, Prat, E, El Nahas, R, Missous, G, Bodoy, S, Sathappan, A, Al-Aghbar, MA, Mayayo, C, Olivé, M, Busquets-Rius, S, Sebastián, D, Zorzano, A, Palacin, M, van Panhuys, N, Nunes, V. Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis. Journal of Cachexia Sarcopenia and Muscle. 2025; 16(3)DOI:10.1002/jcsm.13847. PMID:40546137. IF:9.100(Q1/1D).

Gutierrez-Gutierrez, G, Gomez-Ballesteros, R, Sotoca, J, Ares, A, Villaverde, R, Reyes, V, Armangue, T, Salas, E, Diaz-Abos, P, Rebollo, P, Sarmiento, M, Escobar, I, Maurino, J, Querol, L. Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol. PLoS One. 2025; 20(4)DOI:10.1371/journal.pone.0322168. PMID:40261907. IF:2.600(Q2/4D).

Valls, A, Ruiz-Roldán, C, Immanuel, J, Alonso-Martín, S, Gallardo, E, Fernández-Torrón, R, Bonilla, M, Lersundi, A, Hernández-Laín, A, Domínguez-González, C, Vílchez, JJ, Iruzubieta, P, de Munain, AL, Sáenz, A. The Role of Integrin ß1D Mislocalization in the Pathophysiology of Calpain 3-Related Limb-Girdle Muscular Dystrophy. Cells. 2025; 14(6)DOI:10.3390/cells14060446. PMID:40136695. IF:5.200(Q2/3D).

Slioui, A, Tammam, G, Vanoli, F, Della Marina, A, Vohanka, S, Gilhus, NE, Moroni, I, Leite, MI, Piehl, F, Antozzi, C, Pini, J, Stascheit, F, Attarian, S, Santos, E, Verschuuren, J, Canonge, L, Garcia, J, Perriard, C, Cortés-Vicente, E, Mantegazza, R, Meisel, A, Sacconi, S. Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03520-3. PMID:40069719. IF:3.500(Q2/4D).

Caballero-avila, M, Martin-Aguilar, L, Pascual-Goni, E, Michael, MR, Koel-Simmelink, MJA, Hoeftberger, R, Wanschitz, J, Alonso-Jimenez, A, Armangue, T, Baars, AE, Carbayo, A, Castek, B, Collet-Vidiella, R, De Winter, J, del Real, MA, Delmont, E, Diamanti, L, Doneddu, PE, Hiew, FL, Gallardo, E, Gonzalez, A, Grinzinger, S, Horga, A, Iglseder, S, Jacobs, BC, Jauregui, A, Killestein, J, Pozza, EL, Martinez-Martinez, L, Nobile-Orazio, E, Ortiz, N, Perez-Perez, H, Poppert, KN, Ripellino, P, Roche, JC, de Rivera, FJR, Rostasy, K, Sparasci, D, Tejada-Illa, C, Teunissen, CCE, Vegezzi, E, Xucla-Ferrarons, T, Zach, F, Wieske, L, Eftimov, F, Lleixa, C, Querol, L. Long-Term Follow Up in Anti-Contactin-1 Autoimmune Nodopathy. ANNALS OF NEUROLOGY. 2025; 97(3)DOI:10.1002/ana.27142. PMID:39601182. IF:7.700(Q1/1D).

Querol, L, Dalakas, MC. The Discovery of Autoimmune Nodopathies and the Impact of IgG4 Antibodies in Autoimmune Neurology. Neurology-Neuroimmunology & Neuroinflammation. 2025; 12(1)DOI:10.1212/NXI.0000000000200365. PMID:39671536. IF:7.500(Q1/1D).

Reyes-Leiva, D, Carbayo, A, Vesperinas-Castro, A, Rojas-Garcia, R, Querol, L, Turon-Sans, J, Pla-Junca, F, Olivé, M, Gallardo, E, Pujades-Rodriguez, M, Cortés-Vicente, E. Persistent symptoms, exacerbations and drug side effects despite treatment in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32(1)DOI:10.1111/ene.16463. PMID:39624955. IF:3.900(Q1/3D).

Cortes-Vicente, E, Guerrero-Sola, A, Caballero-Martinez, F, Campos-Lucas, FJ, Gómez-Salgado, J, Monge-Martin, D, Alvarez-Velasco, R. Practitioner's perception of myasthenia gravis management recommendations in clinical practice: a cross-sectional survey study. Therapeutic Advances in Chronic Disease. 2025; 16DOI:10.1177/20406223251368063. PMID:40949050. IF:2.800(Q2/5D).

Leonhard, SE, Papri, N, Querol, L, Rinaldi, S, Shahrizaila, N, Jacobs, BC. Guillain-Barre syndrome. Nature Reviews Disease Primers. 2024; 10(1)DOI:10.1038/s41572-024-00580-4. PMID:39702645. IF:60.600(Q1/1D).

Seminario, FD, Aventin, BP, Eiros, R, Freire, JL, Sevilla, T, Carbayo, A, Llongueras, P, Garcia-Alvarez, A, Ripoll-Vera, T, Macias, R, Vilches, S, Ruiz-Bustillo, S, Achaga, XA, Ordas, JG, Gonzalez-Costello, J. Hereditary transthyretin amyloidosis caused by Val142Ile variant in Spain: phenotypic characteristics, geographic distribution and population frequency. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.2073. PMID:. IF:35.600(Q1/1D).

Gawinska, KA, García, MF, Osorio, AN, Paradas, C, Sotoca, J, Povedano, M, Moreno, A, Henao, M, Gil, C, Rojas, R, Caravaca, MG, Grimalt, M, Torron, RF, Jericó, I, Campos, OG, de Laguna, LTB, Hervás, D, Tizzano, E, Costa, JV. Natural history of spinal muscular atrophy patients with 3 and 4 copies of SMN2 gene - data from the national Spanish registry (CUIDAME). NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.461. PMID:. IF:2.800(Q2/5D).

Collins, C, Gokul-Nath, R, Katsikis, P, Fernández-Simón, E, Villalobos, E, Monceau, A, Reza, M, Mehra, P, Laidler, Z, Clark, J, Rojas-García, R, Tasca, G, Marini-Bettolo, C, Diaz-Manera, J. SnRNAseq analysis of muscle samples of patients with SMA reveals novel pathogenic pathways and open avenues for new therapeutic strategies. NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.611. PMID:. IF:2.800(Q2/5D).

Hilsden, H, James, M, Dressman, HG, Rufibach, L, Day, J, Mendell, J, Torron, RF, Harms, M, Pestronk, A, Vissing, J, Desai, U, Yoshimura, M, Shin, J, Mozaffar, T, Stojkovic, T, Pegoraro, E, Rivas, JB, Olive, M, Paradas, C, Straub, V. The International Clinical Outcome Study for Dysferlinopathy II: validation of motor outcome measures in a new patient cohort. NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.276. PMID:. IF:2.800(Q2/5D).

Marín, RM, Leiva, DR, Osorio, AN, Muelas, N, Domínguez, C, Marcos, IR, Paradas, C, Olivé, M, Matas, A, Caravaca, MG, Romero, MB, Mendoza, M, de León, J, Gutiérrez, A, Rabasa, M, Segovia, S, Manera, JD. Spanish Pompe Registry: overview based on the 130 patients included. NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.732. PMID:. IF:2.800(Q2/5D).

Segarra-Casas, A, Domínguez-González, C, Natera-De-Benito, D, Ortez, C, Nascimiento, A, Hernández-Laín, A, Kapetanovic, S, Rodríguez, M, González-Mera, L, Nedkova, V, Fernández-Torrón, R, López-de Munain, A, Jimenez-Mallebrera, C, Rodríguez-Santiago, B, Gallardo, E, Olivé, M, Gallano, P, González-Quereda, L. RNA sequencing as a diagnostic tool in a cohort of 54 undiagnosed patients with neuromuscular diseases. NEUROMUSCULAR DISORDERS. 2024; 43DOI:. PMID:. IF:2.800(Q2/5D).

Monreal, E, Medrano, N, Rodriguez, ABC, Dominguez, JMG, Querol, L, Lallana, JM, Landete, L, Garcia, ME, Morales, EA, Meca, V, Yelamos, SM, Maurino, J, Gómez, R, Guimerans, LMV. Attitudes towards serum neurofilament light chain testing: The role of evidence-based innovation among neurologists. Multiple Sclerosis Journal. 2024; 30(3)DOI:. PMID:. IF:5.000(Q1/2D).

Rodriguez, ABC, Medrano, N, Guimerans, LMV, Querol, L, Lallana, JM, Yelamos, SM, Landete, L, Dominguez, JMG, Gómez, R, Meca, V, Morales, EA, Maurino, J, Garcia, ME, Mora, P, Monreal, E, Saposnik, G. Empathy in multiple sclerosis care: Differences between female and male neurologists. Multiple Sclerosis Journal. 2024; 30(3)DOI:. PMID:. IF:5.000(Q1/2D).

Querol L, De Sèze J, Dysgaard T, Levine T, Rao TH, Rivner M, Hartung HP, Kiessling P, Shimizu S, Marmol D, Bozorg A, Colson AO, Massow U, Eftimov F, CIDP01 Study Investigators. Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2024; 95(9)DOI:10.1136/jnnp-2023-333112. PMID:38729747. IF:(Q/D).

Andújar-Sánchez, F, Cantó-Santos, J, Fernández-Garibay, X, Valls-Roca, L, Tobías, E, Guitart-Mampel, M, García-García, FJ, Laudo, B, Vilaseca-Capel, A, Padrosa, J, Moreno-Lozano, PJ, Grau-Junyent, JM, Matas, A, Gallardo, E, Fernández-Costa, J, Ramón-Azcón, J, Milisenda, JC, Garrabou, G. Novel patient-derived 2D and 3D muscle models in inclusion body myositis. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

Asl, AM, Mehdizadeh, M, Kulisevsky, J, Sabet, A, Sharabiani, PTA, Mehdizadeh, H, Ashayeri, H, Taghizadeh, G. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease. DISABILITY AND REHABILITATION. 2022; 44(10)DOI:10.1080/09638288.2020.1813337. PMID:32924645. IF:2.200(Q2/4D).

Aracil-Bolanos, I, Sampedro, F, Marin-Lahoz, J, Horta-Barba, A, Martinez-Horta, S, Gonzalez-de-Echavarri, JM, Perez-Perez, J, Bejr-Kasem, H, Pascual-Sedano, B, Boti, M, Campolongo, A, Izquierdo, C, Gironell, A, Gomez-Anson, B, Kulisevsky, J, Pagonabarraga, J. Tipping the scales: how clinical assessment shapes the neural correlates of Parkinson's disease mild cognitive impairment. Brain Imaging and Behavior. 2022; 16(2)DOI:10.1007/s11682-021-00543-3. PMID:34553331. IF:3.200(Q2/5D).

Aracil-Bolanos, I, Martinez-Horta, S, Gonzalez-de-Echavarri, JM, Sampedro, F, Perez-Perez, J, Horta, A, Campolongo, A, Izquierdo, C, Gomez-Anson, B, Pagonabarraga, J, Kulisevsky, J. Structure and Dynamics of Large-Scale Cognitive Networks in Huntington's Disease. MOVEMENT DISORDERS. 2022; 37(2)DOI:10.1002/mds.28839. PMID:34752656. IF:8.600(Q1/1D).

Aretouli, E, Chondrogiorgi, M, Dede, O, Koutsonida, M, Lafi, C, Konstantinopoulou, E, Kulisevsky, J, Kosmidis, MH, Konitsiotis, S. The Parkinson's Disease-Cognitive Rating Scale: Greek Normative Data, Clinical Utility and Cultural Considerations. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2022; 35(5)DOI:10.1177/08919887211049110. PMID:34663111. IF:2.600(Q3/7D).